Avigan Tablet 200 mg

Avigan Tablet 200 mg contains Favipiravir (200mg). Prescription required.

Treatment of mild to moderate COVID-19 infection (as per prevailing local guidelines/label); investigational/off-label use has been reported for other RNA viral infections.

Favipiravir is an antiviral that is converted in the body to an active ribofuranosyl triphosphate form. It inhibits viral RNA-dependent RNA polymerase, thereby preventing replication of susceptible RNA viruses.

Take by mouth as prescribed by a doctor. Usually taken after food with water at the same time(s) each day; do not crush/chew unless advised. Dose and duration depend on indication and clinical guidelines.

Nausea, vomiting, diarrhoea, abdominal pain, increased liver enzymes (ALT/AST), increased uric acid (hyperuricaemia), rash, dizziness

Prescription-only antiviral; use only under medical supervision. Contraindicated/not recommended in pregnancy; women of childbearing potential should use effective contraception during treatment and for a period after stopping (per prescriber advice). Men should use contraception during treatment and after stopping (per prescriber advice) due to potential risk to fetus. Use with caution in liver disease, renal impairment and in patients with gout/hyperuricaemia; monitor liver function and uric acid as advised. Stop and seek care if severe rash/allergy occurs.

Pyrazinamide (may increase uric acid), theophylline (may increase favipiravir levels), repaglinide (risk of increased repaglinide exposure/hypoglycaemia), drugs causing hyperuricaemia or hepatotoxicity (additive risk)

Store at room temperature (below 25°C), protected from moisture and light. Keep in original pack and out of reach of children.

Fabiflu 200 Tablet, Favivir 200 Tablet, Faviwin 200 Tablet, Favinext 200 Tablet, Favipir 200 Tablet